138 related articles for article (PubMed ID: 35278135)
1. Tooth extractions prior to chemoradiation or bioradiation are associated with weight loss during treatment for locally advanced oropharyngeal cancer.
Buurman DJM; Willemsen ACH; Speksnijder CM; Baijens LWJ; Hoeben A; Hoebers FJP; Kessler P; Schols AMWJ
Support Care Cancer; 2022 Jun; 30(6):5329-5338. PubMed ID: 35278135
[TBL] [Abstract][Full Text] [Related]
2. Disease-induced and treatment-induced alterations in body composition in locally advanced head and neck squamous cell carcinoma.
Willemsen ACH; Hoeben A; Lalisang RI; Van Helvoort A; Wesseling FWR; Hoebers F; Baijens LWJ; Schols AMWJ
J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):145-159. PubMed ID: 31536685
[TBL] [Abstract][Full Text] [Related]
3. Prediction model for tube feeding dependency during chemoradiotherapy for at least four weeks in head and neck cancer patients: A tool for prophylactic gastrostomy decision making.
Willemsen ACH; Kok A; van Kuijk SMJ; Baijens LWJ; de Bree R; Devriese LA; Hoebers FJP; Lalisang RI; Schols AMWJ; Terhaard CHJ; Hoeben A
Clin Nutr; 2020 Aug; 39(8):2600-2608. PubMed ID: 31839429
[TBL] [Abstract][Full Text] [Related]
4. The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy.
Yilmaz B; Somay E; Topkan E; Kucuk A; Pehlivan B; Selek U
BMC Oral Health; 2023 Apr; 23(1):231. PubMed ID: 37081475
[TBL] [Abstract][Full Text] [Related]
5. Development and external validation of a prediction model for tube feeding dependency for at least four weeks during chemoradiotherapy for head and neck cancer.
Willemsen ACH; Kok A; Baijens LWJ; de Boer JP; de Bree R; Devriese LA; Driessen CML; van Herpen CML; Hoebers FJP; Kaanders JHAM; Karsten RT; van Kuijk SMJ; Lalisang RI; Navran A; Pereboom SR; Schols AMWJ; Terhaard CHJ; Hoeben A
Clin Nutr; 2022 Jan; 41(1):177-185. PubMed ID: 34883306
[TBL] [Abstract][Full Text] [Related]
6. Dental Extractions Before Radiation Therapy and the Risk of Osteoradionecrosis in Patients With Head and Neck Cancer.
Lee J; Hueniken K; Cuddy K; Pu J; El Maghrabi A; Hope A; Hosni A; Glogauer M; Watson E
JAMA Otolaryngol Head Neck Surg; 2023 Dec; 149(12):1130-1139. PubMed ID: 37856115
[TBL] [Abstract][Full Text] [Related]
7. Do pre-irradiation dental extractions reduce the risk of osteoradionecrosis of the mandible?
Chang DT; Sandow PR; Morris CG; Hollander R; Scarborough L; Amdur RJ; Mendenhall WM
Head Neck; 2007 Jun; 29(6):528-36. PubMed ID: 17230555
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of primary radiotherapy versus surgery in elderly patients with locally advanced oropharyngeal squamous cell carcinoma.
Sher DJ; Yan J; Day A; Sumer BD; Pham NL; Khan S; Zhu H
Oral Oncol; 2019 Jan; 88():18-26. PubMed ID: 30616791
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy-associated dental extractions and osteoradionecrosis.
Beech NM; Porceddu S; Batstone MD
Head Neck; 2017 Jan; 39(1):128-132. PubMed ID: 27473832
[TBL] [Abstract][Full Text] [Related]
10. Disease outcome and associated factors after definitive platinum based chemoradiotherapy for advanced stage HPV-negative head and neck cancer.
de Roest RH; van der Heijden M; Wesseling FWR; de Ruiter EJ; Heymans MW; Terhaard C; Vergeer MR; Buter J; Devriese LA; de Boer JP; Navran A; Hoeben A; Vens C; van den Brekel M; Brakenhoff RH; Leemans CR; Hoebers F
Radiother Oncol; 2022 Oct; 175():112-121. PubMed ID: 35973619
[TBL] [Abstract][Full Text] [Related]
11. Concurrent use of cisplatin or cetuximab with definitive radiotherapy for locally advanced head and neck squamous cell carcinomas.
Levy A; Blanchard P; Bellefqih S; Brahimi N; Guigay J; Janot F; Temam S; Bourhis J; Deutsch E; Daly-Schveitzer N; Tao Y
Strahlenther Onkol; 2014 Sep; 190(9):823-31. PubMed ID: 24638267
[TBL] [Abstract][Full Text] [Related]
12. Dental extraction, intensity-modulated radiotherapy of head and neck cancer, and osteoradionecrosis : A systematic review and meta-analysis.
Balermpas P; van Timmeren JE; Knierim DJ; Guckenberger M; Ciernik IF
Strahlenther Onkol; 2022 Mar; 198(3):219-228. PubMed ID: 35029717
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiation.
Guo TW; Saiyed F; Yao CMKL; Kiong KL; Martinez J; Sacks R; Lee JJ; Moreno AC; Frank SJ; Rosenthal DI; Glisson BS; Ferrarotto R; Mott FE; Johnson FM; Myers JN
Cancer; 2021 Aug; 127(16):2916-2925. PubMed ID: 33873251
[TBL] [Abstract][Full Text] [Related]
14. Incidence of osteoradionecrosis of the jaws: a retrospective study of 620 patients with head and neck cancer.
Kabir R; Durand R; Roberge D; Dufresne E; Nguyen-Tân PF
Gen Dent; 2022; 70(4):72-77. PubMed ID: 35749251
[TBL] [Abstract][Full Text] [Related]
15. Comparison of acute toxicities associated with cetuximab-based bioradiotherapy and platinum-based chemoradiotherapy for head and neck squamous cell carcinomas: A single-institution retrospective study in Japan.
Sakashita T; Homma A; Hatakeyama H; Furusawa J; Kano S; Mizumachi T; Iizuka S; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Fukuda S
Acta Otolaryngol; 2015 Aug; 135(8):853-8. PubMed ID: 25814008
[TBL] [Abstract][Full Text] [Related]
16. Tooth extraction prior to radiotherapy for oropharyngeal cancer increases the risk of osteoradionecrosis.
Slettvoll S; Thaning RC; Pedersen TØ
J Oral Sci; 2023 Mar; 65(2):87-89. PubMed ID: 36858604
[TBL] [Abstract][Full Text] [Related]
17. The extent of unnecessary tooth loss due to extractions prior to radiotherapy based on radiation field and dose in patients with head and neck cancer.
Buurman DJM; Speksnijder CM; Granzier ME; Timmer VCML; Hoebers FJP; Kessler P
Radiother Oncol; 2023 Oct; 187():109847. PubMed ID: 37543058
[TBL] [Abstract][Full Text] [Related]
18. Association between dental extraction after radiotherapy and osteoradionecrosis: A multi-centre retrospective study.
Saito I; Hasegawa T; Kawashita Y; Kato S; Yamada SI; Kojima Y; Ueda N; Umeda M; Shibuya Y; Kurita H; Kirita T; Akashi M
Oral Dis; 2022 May; 28(4):1181-1187. PubMed ID: 33650256
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer.
Shirasu H; Yokota T; Hamauchi S; Onozawa Y; Ogawa H; Onoe T; Onitsuka T; Yurikusa T; Mori K; Yasui H
BMC Cancer; 2020 Mar; 20(1):182. PubMed ID: 32131771
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment Systemic Immune-Inflammation Index Predict Needs for Teeth Extractions for Locally Advanced Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy.
Yilmaz B; Somay E; Selek U; Topkan E
Ther Clin Risk Manag; 2021; 17():1113-1121. PubMed ID: 34703240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
